Succinimide

This page covers all Succinimide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-dependent T-type calcium channel subunit alpha-1G.

Targets

Voltage-dependent T-type calcium channel subunit alpha-1G

Marketed (1)

• Zarontin · Pfizer · Neuroscience
  Suppresses paroxysmal three cycle per second spike and wave activity associated with absence seizures.